
Related topics: Regulatory & Safety, Globalisation
China will become the third largest pharmaceutical market in the world in 2011 according to new research by IMS Health, which also increased its list of fast growing, or “pharmerging,” markets from seven to 17.
IMS said that drug sales in China will reach a value in excess of $40bn (€29.2bn) in drug sales in 2013, with branded generic being the key growth drivers.
The study also predicts that the 17 pharmerging markets are set to expand by $90bn (€65.2bn) over the next few years, contributing 48 per cent of the world pharmaceutical market’s growth by 2013.
In addition, the researchers also forecast that the markets in Brazil, Russia and India will grow by as much as $15bn over the next three years.
Copyright - Unless otherwise stated all contents of this web site are © 2012 - William Reed Business Media SAS - All Rights Reserved - For permission to reproduce any contents of this web site, please email our Syndication department copyright@wrbm.com - Full details for the use of materials on this site can be found in the Terms & Conditions
© 2012 - William Reed Business Media SAS - All rights reserved. ![]()